Found: 16
Select item for more details and to access through your institution.
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 2649, doi. 10.2147/PPA.S365117
- By:
- Publication type:
- Article
Effects of variations in access to care for children with atopic dermatitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1337, doi. 10.1007/s13555-022-00731-z
- By:
- Publication type:
- Article
Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide.
- Published in:
- Journal of the Endocrine Society, 2022, v. 6, n. 6, p. 1, doi. 10.1210/jendso/bvac057
- By:
- Publication type:
- Article
Burden of hyperphagia and obesity in Bardet–Biedl syndrome: a multicountry survey.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, p. 1, doi. 10.1186/s13023-023-02723-4
- By:
- Publication type:
- Article
Caregiver burden in Bardet-Biedl syndrome: findings from the CARE-BBS study.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, p. 1, doi. 10.1186/s13023-023-02692-8
- By:
- Publication type:
- Article
Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet–Biedl syndrome: phase 3 trial results.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-022-02602-4
- By:
- Publication type:
- Article
Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiency.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health state utilities associated with hyperphagia: Data for use in cost‐utility models.
- Published in:
- Obesity Science & Practice, 2023, v. 9, n. 4, p. 376, doi. 10.1002/osp4.652
- By:
- Publication type:
- Article
Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210517
- By:
- Publication type:
- Article
Interview-Based Patient- and Caregiver-Reported Experiences of Hunger and Improved Quality of Life with Setmelanotide Treatment in Bardet-Biedl Syndrome.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 2394, doi. 10.1007/s12325-023-02443-y
- By:
- Publication type:
- Article
Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1772, doi. 10.1007/s12325-022-02059-8
- By:
- Publication type:
- Article
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
- Published in:
- ClinicoEconomics & Outcomes Research, 2019, v. 11, p. 117, doi. 10.2147/CEOR.S183076
- By:
- Publication type:
- Article